Prelude Therapeutics Incorporated · NASDAQ:PRLD
Deerfield Mgmt, L.P.'s stake in Prelude Therapeutics Incorporated fell below 5% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 13, 2025
Deerfield Mgmt, L.P.'s stake in Prelude Therapeutics Incorporated fell below 5%, 0 shares, as a passive investor on Dec 31, 2024. Filed Feb 13, 2025 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Deerfield Mgmt, L.P. | 0% | 0 |
| Deerfield Management Company, L.P. | 0% | 0 |
| Deerfield Partners, L.P. | 0% | 0 |
| James E. Flynn | 0% | 0 |
Source
Related
- Prelude Therapeutics Incorporated
- Deerfield Mgmt, L.P.
- Prelude Therapeutics Incorporated shareholders
- Schedule 13G · Soleus Capital Management, L.P. · Jul 8, 2026
- Form 4 · Shah Rajeev M. · Apr 28, 2026
- Schedule 13G · Ra Capital Management, L.P. · Apr 28, 2026
- Form 4 · Bonita David P · Apr 23, 2026
- Form 4 · OrbiMed Genesis GP LLC · Apr 23, 2026